Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism TNFR1 inhibitors(Tumor necrosis factor receptor superfamily member 1A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Enosi Life Sciences Corp.Startup |
Active Organization Enosi Life Sciences Corp.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | Enosi Life Sciences Corp.Startup | 16 Jun 2024 |
Inflammation | Preclinical | US | Enosi Life Sciences Corp.Startup | 16 Jun 2024 |